In vitro diagnostics needs seismic change
The current state of in vitro diagnostics (IVDs) is no longer fit for purpose. In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits.
細胞治療にかかる費用や時間の負担は減らせるのか？
Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in synthetic biology, Matthew Jones is part of a team addressing this issue in an ambitious project with exciting potential.
PureSentry：リアルタイムコンタミネーション検出が 細胞治療にもたらす変革
This whitepaper goes behind the scenes of a significant breakthrough for contamination detection in cell therapy monitoring. It tells the story of PureSentry, a prototype device for on-line, real-time detection.
Neuropathy screening from diabetic retinopathy images
People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.
微細藻類の培養による環境廃棄物負荷の軽減
本ホワイトペーパーでは、「ゴミをお金に換える」ことが、様々な分野でどのように先行者利益を得るチャンスを企業にもたらすかを解説します。明確な問題解決アプローチを用い、単に炭素を捕捉する方法として考えられていたものが、価値のある生物由来化合物の生産という利益をもたらす可能性があることを紹介します。